Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shijiazhuang Yiling Pharmaceutical is one of China's largest integrated pharmaceutical companies specializing in both traditional Chinese medicines and Western pharmaceuticals across key therapeutic areas like cardiovascular disease and infectious diseases including COVID/influenza treatments. The company operates globally with significant export business and maintains high-quality manufacturing standards recognized by multiple international agencies. Its product portfolio includes several well-known patented herbal medicines alongside small molecules under development or already commercialized domestically or abroad.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shijiazhuang Yiling Pharmaceutical.